Publication: Authors’ reply
dc.contributor.author | Xue Yan Wang | en_US |
dc.contributor.author | Margaret Lim-Jurado | en_US |
dc.contributor.author | Narayanan Prepageran | en_US |
dc.contributor.author | Pongsakorn Tantilipikorn | en_US |
dc.contributor.author | De Yun Wang | en_US |
dc.contributor.other | Capital Medical University China | en_US |
dc.contributor.other | De La Salle Health Sciences Institute | en_US |
dc.contributor.other | University of Malaya | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Yong Loo Lin School of Medicine | en_US |
dc.date.accessioned | 2018-12-11T02:29:04Z | |
dc.date.accessioned | 2019-03-14T08:04:22Z | |
dc.date.available | 2018-12-11T02:29:04Z | |
dc.date.available | 2019-03-14T08:04:22Z | |
dc.date.issued | 2016-11-24 | en_US |
dc.identifier.citation | Therapeutics and Clinical Risk Management. Vol.12, (2016), 1779-1781 | en_US |
dc.identifier.issn | 1178203X | en_US |
dc.identifier.issn | 11766336 | en_US |
dc.identifier.other | 2-s2.0-85000623672 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/43318 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85000623672&origin=inward | en_US |
dc.subject | Chemical Engineering | en_US |
dc.subject | Medicine | en_US |
dc.title | Authors’ reply | en_US |
dc.type | Letter | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85000623672&origin=inward | en_US |